Supercharged immune cells take on advanced melanoma in major new trial
NCT ID NCT05727904
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial is testing whether a powerful combination of two treatments works better than standard immunotherapy alone for people with advanced melanoma that has not been treated yet. The experimental approach uses lifileucel, a personalized therapy made from a patient's own tumor-fighting immune cells, given together with the immunotherapy drug pembrolizumab. About 670 participants will be randomly assigned to receive either the combination or pembrolizumab alone, with the goal of seeing which group has better tumor shrinkage and longer time without cancer growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lifileucel (a personalized cell therapy made from a patient's own tumor-fighting immune cells) plus pembrolizumab (an immunotherapy drug)
- What this could lead to
- If successful, this combination could offer a more effective first-line treatment for advanced melanoma, potentially shrinking tumors and delaying progression better than standard immunotherapy alone.
- What could go wrong
- This is an early Phase 3 trial, so results are not yet proven. The cell therapy requires surgery and a complex manufacturing process, and side effects from lymphodepletion and IL-2 can be severe. Not all patients may benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allegheny Health Network
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
-
Azienda Ospedaliera Universitaria Senese
RECRUITINGSiena, Italy
-
Azienda Ospedaliero Universitaria Pisana
RECRUITINGPisa, Tuscany, 56100, Italy
-
Baptist Cancer Center
RECRUITINGBartlett, Tennessee, 37920, United States
-
Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center
WITHDRAWNDetroit, Michigan, 48201, United States
-
Beaston West of Scotland Canter Centre
RECRUITINGGlasgow, G120YN, United Kingdom
-
Bundang Medical Center - CHA University
RECRUITINGSeongnam-si, Gyeonggi-do, South Korea
-
California Pacific Medical Center
RECRUITINGSan Francisco, California, 94107, United States
-
Centre Hospitalier Universitaire Vaudois Lausanne
RECRUITINGLausanne, 1011, Switzerland
-
Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu
RECRUITINGNantes, 44093, France
-
Centre hospitalier de l'Université de Montréal
RECRUITINGMontreal, Quebec, H2L 4M1, Canada
-
Centro di Riferimento Oncologico IRCCS
RECRUITINGAviano, Friuli Venezia Giulia, 33081, Italy
-
Charité - Universitätsmedizin Berlin
RECRUITINGBerlin, Germany, 13353, Germany
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
-
Clínica Universitaria de Navarra
RECRUITINGPamplona, 31008, Spain
-
Consorcio Hospital General Universitario de Valencia
RECRUITINGValencia, 46014, Spain
-
Dartmouth-Hitchcock Medical Center (DHMC) - Norris Cotton Cancer Center
RECRUITINGLebanon, New Hampshire, 03756, United States
-
Fiona Stanley Hospital
RECRUITINGMurdoch, Western Australia, 6150, Australia
-
Flinders Medical Centre
RECRUITINGBedford Park, 5042, Australia
-
Freeman Hospital
RECRUITINGNewcastle upon Tyne, England, NE7 7DN, United Kingdom
-
Greenslopes Private Hospital
RECRUITINGGreenslopes, Queensland, 4120, Australia
-
Guy's Hospital
RECRUITINGLondon, SE1 9RT, United Kingdom
-
HM Centro Integral Oncologico Clara Campal
RECRUITINGMadrid, Spain, 28050, Spain
-
Hadassah Medical Center
RECRUITINGJerusalem, Israel
-
Helsinki University Hospital Comprehensive Cancer Center
RECRUITINGHelsinki, Finland, 290, Finland
-
Henry Ford Health
RECRUITINGDetroit, Michigan, 48202, United States
-
Hopital Saint Louis
RECRUITINGParis, 75475, France
-
Hospital 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, 8036, Spain
-
Hospital General Universitario Gregorio Maranon
RECRUITINGMadrid, 28007, Spain
-
Hospital Regional Universitario de Malaga - Hospital General
RECRUITINGMálaga, Málaga, 29016, Spain
-
Hospital Universitari Vall dHebron
WITHDRAWNBarcelona, 08035, Spain
-
Hospital Universitario Madrid Sanchinarro - CIOCC
RECRUITINGMadrid, 28050, Spain
-
Hospital Universitario Marques de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
-
Hospital Universitario Quirónsalud Madrid
RECRUITINGMadrid, 28223, Spain
-
Hospital Universitario Ramon y Cajal
RECRUITINGMadrid, Spain
-
Hospital Universitario Virgen Macarena
RECRUITINGSeville, 41009, Spain
-
ICO l'Hospitalet - Hospital Duran i Reynals
RECRUITINGBarcelona, 8908, Spain
-
Institut Català d'Oncologia (ICO)
RECRUITINGBarcelona, Spain, 8908, Spain
-
Institut Paoli Calmettes
RECRUITINGMarseille, 13009, France
-
Instituto Oncologico Rosell
RECRUITINGBarcelona, 08028, Spain
-
Intermountain Health
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Istituto Europeo Di Oncologia
WITHDRAWNMilan, 20139, Italy
-
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale
RECRUITINGNaples, Napoli, 80131, Italy
-
Istituto Romagnolo per lo Studio dei Tumori
RECRUITINGMeldola, Forlì-Cesena, 47014, Italy
-
Klinikum Rechts der Isar der Technischen Universität München
RECRUITINGMunich, 81675, Germany
-
Korea University Anam Hospital
RECRUITINGSeoul, 2841, South Korea
-
MD Anderson Cancer Center at Cooper
RECRUITINGCamden, New Jersey, 08103, United States
-
National Cancer Centre Singapore
RECRUITINGSingapore, Singapore, 168582, Singapore
-
National Cancer Institute
RECRUITINGBethesda, Maryland, 20814, United States
-
Nederlands Kanker Instituut
RECRUITINGAmsterdam, 1066 CX, Netherlands
-
Ohio State University
RECRUITINGColumbus, Ohio, 43201, United States
-
Oncology Hematology Care
RECRUITINGCincinnati, Ohio, 45226, United States
-
Orlando Health Cancer Institute
RECRUITINGOrlando, Florida, 32806, United States
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, Victoria, 3000, Australia
-
Princess Margaret Cancer Centre
RECRUITINGToronto, M5G, Canada
-
Queen Elizabeth Hospital Birmingham
RECRUITINGBirmingham, England, B15 2GW, United Kingdom
-
Royal Marsden Hospital
RECRUITINGChelsea, London, SW3 6JJ, United Kingdom
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
Sahlgrenska Universitetssjukhuset
RECRUITINGGothenburg, Västra Götaland County, SE-41346, Sweden
-
Samsung Medical Center
RECRUITINGSeoul, South Korea, 135-890, South Korea
-
Sarah Cannon Research Institute UK
RECRUITINGLondon, W1G 6AD, United Kingdom
-
Seoul National University Hospital
RECRUITINGSeoul, 3080, South Korea
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 3722, South Korea
-
Sheba Medical Center
RECRUITINGRamat Gan, 52621, Israel
-
St. Luke's Cancer Center - Anderson
WITHDRAWNEaston, Pennsylvania, 18045, United States
-
Swedish Cancer Institute
RECRUITINGEdmonds, Washington, 98026, United States
-
Tel Aviv Sourasky Medical Center
RECRUITINGTel Aviv, 6423906, Israel
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90007, United States
-
Universitair Ziekenhuis Brussel - Oncologisch Centrum
RECRUITINGJette, Belgium
-
University of Alabama at Birmingham: The Kirklin Clinic
RECRUITINGBirmingham, Alabama, 35233, United States
-
University of Colorado Cancer Center
RECRUITINGAurora, Colorado, 80045, United States
-
University of Illinois Hospital & Health Sciences System
WITHDRAWNChicago, Illinois, 60612, United States
-
University of Kansas
WITHDRAWNKansas City, Kansas, 66205, United States
-
University of Louisville - James Graham Brown Cancer Center
WITHDRAWNLouisville, Kentucky, 40202, United States
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
-
Universitätsklinikum Carl Gustav Carus
RECRUITINGDresden, 1307, Germany
-
Universitätsklinikum Hamburg-Eppendorf
RECRUITINGHamburg, 20251, Germany
-
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
RECRUITINGLübeck, 23562, Germany
-
Virginia Commonwealth University
WITHDRAWNRichmond, Virginia, 23298, United States
-
Westmead Hospital
RECRUITINGWestmead, NSW 2145, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer reveal whether immunotherapy is working?
- Can a new nucleotide analogue boost cancer treatment?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Could a lighter immunotherapy schedule keep advanced cancers in check?